HypogonadismPhase 4TRAVERSENCT03518034
A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men
A Phase 4 study testing AndroGel® in people with Hypogonadism and Cardiovascular Diseases, run by AbbVie at 384 sites in 2 countries.
Trial summary
This is a double-blinded and placebo-controlled study of topical testosterone replacement therapy (TRT) in symptomatic hypogonadal men with pre-existing cardiovascular disease (CVD) or increased risk for CVD. Read more about this study
- Who is it for?
- Ages 45 to 80 years, men only
- Conditions the study is for
- Hypogonadism, Cardiovascular Diseases
- What is being tested?
- AndroGel®
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 5,246 participants
- Where
- 384 sitesin 2 countries
- Study dates
- 3 May 2018to 19 Jan 2023
- Phase
- Phase 4
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 45 to 80 years
- Men only
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Men between 45 and 80 years age
- Participants with low serum testosterone concentrations (< 300 ng/dL) who exhibit at least one sign or symptom of hypogonadism and have evidence of cardiovascular (CV) disease or are at an increased risk for CV disease.
Who cannot join
- Participants with congenital or acquired hypogonadism for whom long-term therapy with placebo would not be medically appropriate
- Participants with prostate specific antigen (PSA) > 3.0 ng/mL (or 1.5 if on 5-alpha reductase inhibitors)
- Participants who have been treated with testosterone in the past 6 months and for whom testosterone therapy is contraindicated
- Confirmed testosterone < 100 ng/dL
- Body Mass Index (BMI) > 50
- Hemoglobin A1c (HbA1C) > 11%
Show all 9Show fewer
- Hematocrit (Hct) > 50%
- Estimated Glomerular Filtration Rate (eGFR) < 30 ml/min
- History of deep vein thrombosis or pulmonary embolism or prostate cancer or heart failure (Class III and IV).
Trial locations and contacts
384 sites in 2 countries.
305 sites in 2 countries
United States300 sites
Biofortis, Inc. /ID# 167856
Addison, Illinois, 60101-4219
Synexus Clinical Research, Inc /ID# 202976
Akron, Ohio, 44311
Wright Clinical Research, LLC /ID# 210864
Alabaster, Alabama, 35007-8978
Albany Stratton VA Medical Center /ID# 167862
Albany, New York, 12208
NM Clinical Research & Osteoporosis Center, Inc /ID# 170386
Albuquerque, New Mexico, 87106
Alexandria Cardiology Clinic /ID# 170463
Alexandria, Louisiana, 71301-6826
Alaska Urological Institute /ID# 167894
Anchorage, Alaska, 99508
Synexus Clinical Research US, Inc. /ID# 210230
Anderson, South Carolina, 29621-2062
Synexus Clinical Research US, Inc. /ID# 210228
Anderson, South Carolina, 85712-5831
Arlington Family Research Center, Inc /ID# 170366
Arlington, Texas, 76012
Randolph Health Internal Medicine /ID# 168227
Asheboro, North Carolina, 27203
Atlanta Vascular Research Foundation - Atlanta Clinical Research Centers /ID# 170894
Atlanta, Georgia, 30342
Masters of Clinical Research, Inc. /ID# 167950
Augusta, Georgia, 30909
Lynn Institute of Denver /ID# 170312
Aurora, Colorado, 80012
Premier Family Physicians /ID# 167946
Austin, Texas, 78735
Aventura Heart Center /ID# 170354
Aventura, Florida, 33180
American Health Network of IN, LLC (Avon) /ID# 170359
Avon, Indiana, 46123-7960
MidLantic Urology /ID# 170351
Bala-Cynwyd, Pennsylvania, 19004
Maryland Cardiovascular Specialists /ID# 168057
Baltimore, Maryland, 21229-5222
Johns Hopkins University /ID# 203006
Baltimore, Maryland, 21287
DiscoveResearch, Inc. /ID# 170320
Beaumont, Texas, 77701
Pioneer Research Solutions, Inc. /ID# 168062
Beaumont, Texas, 77702-1845
Heritage Valley Medical Group /ID# 170387
Beaver, Pennsylvania, 15009-1957
Northwest Clinical Research Center /ID# 201588
Bellevue, Washington, 98007
Pacific Oaks Medical Group /ID# 170540
Beverly Hills, California, 90211
Simon-Williamson Clinic /ID# 210249
Birmingham, Alabama, 35211-1320
Alabama Clinical Therapeutics /ID# 202982
Birmingham, Alabama, 35235-3430
Cahaba Research, Inc. /ID# 167928
Birmingham, Alabama, 35242
Velocity Clinical Research /ID# 170460
Blue Ash, Ohio, 45242-3763
MB Clinical Research /ID# 202970
Boca Raton, Florida, 33487-3622
Imagine Research of Palm Beach County /ID# 212140
Boynton Beach, Florida, 33435-5610
Helix Biomedics, LLC /ID# 202310
Boynton Beach, Florida, 33436-6634
West Florissant Internists /ID# 170314
Bridgeton, Missouri, 63044
Internal Medicine Associates /ID# 170538
Bridgeton, New Jersey, 08302
Medicor Cardiology /ID# 170436
Bridgewater, New Jersey, 08807
Holston Medical Group (Seasons of Bristol) /ID# 170565
Bristol, Tennessee, 37620-7346
NY Total Medical Care, PC /ID# 170423
Brooklyn, New York, 11215
Meridien Research Inc. - Brooksville /ID# 170556
Brooksville, Florida, 34609
Investigators Research Group, LLC /ID# 170557
Brownsburg, Indiana, 46112
Burke Internal Medicine & Research /ID# 202981
Burke, Virginia, 22015-2234
Cooper Health System /ID# 170417
Camden, New Jersey, 08103-1438
Diabetes and Endocrinology Associates of Stark County Inc /ID# 170356
Canton, Ohio, 44718
Gabrail Cancer Center Research /ID# 170533
Canton, Ohio, 44718
Family Medicine Associates of Texas, PA /ID# 167849
Carrollton, Texas, 75010
Synexus Clinical Research US, INC /ID# 170530
Chandler, Arizona, 85224-6278
Medical Research South, LLC /ID# 203068
Charleston, South Carolina, 29407
OnSite Clinical Solutions, LLC - Hickory /ID# 170449
Charlotte, North Carolina, 28210-8472
PMG Research of Charlotte /ID# 202985
Charlotte, North Carolina, 28277-6594
OnSite Clinical Solutions, LLC /ID# 170349
Charlotte, North Carolina, 28277
OnSite Clinical Solutions, LLC /ID# 170634
Charlotte, North Carolina, 28277
University Diabetes & Endocrine Consultants /ID# 170392
Chattanooga, Tennessee, 37411-5374
Synexus Clinical Research US, Inc /ID# 209956
Chicago, Illinois, 60602-3102
Chicago Clinical Research Institute, Inc /ID# 203190
Chicago, Illinois, 60607
Loretto Hospital.Affnity Clinical Research Institute /ID# 207262
Chicago, Illinois, 60644
Cincinnati Veterans Affairs Medical Center /ID# 170385
Cincinnati, Ohio, 45219
Synexus Research Cincinnati /ID# 209958
Cincinnati, Ohio, 45236
Innovative Research of West Florida /ID# 170360
Clearwater, Florida, 33756-2004
Tampa Bay Medical Res, Inc /ID# 170512
Clearwater, Florida, 33761
Velocity clinical research /ID# 170513
Cleveland, Ohio, 44122
Collierville Medical Specialists /ID# 170328
Collierville, Tennessee, 38017
Lynn Institute of Colorado Springs South /ID# 168231
Colorado Springs, Colorado, 80909-1163
Lynn Institute of the Rockies /ID# 170477
Colorado Springs, Colorado, 80918-1662
Endocrine Consustants Research /ID# 168147
Columbus, Georgia, 31904-4501
Endocrinology Associates, Inc. /ID# 168113
Columbus, Ohio, 43201
Synexus Clinical Research US, Inc. /ID# 210234
Columbus, Ohio, 43212-3119
The Ohio State University Wexner Medical Center - Department of Urology /ID# 170551
Columbus, Ohio, 43212-3153
Aventiv Research Columbus /ID# 170338
Columbus, Ohio, 43213
Optimed Research, Ltd. /ID# 168111
Columbus, Ohio, 43235
ALL Medical Research /ID# 170493
Cooper City, Florida, 33024
3rd Coast Research Associates /ID# 203091
Corpus Christi, Texas, 78413
West Broadway Clinic /ID# 202204
Council Bluffs, Iowa, 51501-3822
Midwest Endocrinology /ID# 202992
Crystal Lake, Illinois, 60012-1809
Veterans Affairs North Texas Health Care System /ID# 170325
Dallas, Texas, 75216
Urology Clinics of North Texas /ID# 203033
Dallas, Texas, 75231-4436
North TX Endocrine Center /ID# 170552
Dallas, Texas, 75231
Synexus Clinical Research US, INC /ID# 170319
Dallas, Texas, 75234-7858
PriMed Clinical Research /ID# 170310
Dayton, Ohio, 45419
Dayton VA Medical Center /ID# 168251
Dayton, Ohio, 45428
Century Clinical Research, Inc /ID# 167597
Daytona Beach, Florida, 32117
Atlanta VAHCS /ID# 170318
Decatur, Alabama, 30033
Seidman Clinical Trials,Delray /ID# 170418
Delray Beach, Florida, 33484-6529
Physicians Research Options, L /ID# 170441
Draper, Utah, 84020-5004
West Coast Research LLC /ID# 167903
Dublin, California, 94568
Heartland Research Associates, LLC /ID# 203031
El Dorado, Kansas, 67042-2184
Union Square Medical Associates,PC /ID# 170346
Elizabeth, New Jersey, 07201-4708
Skyline Medical Center /ID# 168234
Elkhorn, Nebraska, 68022-2889
Centennial Medical Group /ID# 170568
Elkridge, Maryland, 21075
Investigative Clinical Research of Indiana, LLC /ID# 170473
Elwood, Indiana, 46036-3341
Diagnamics Inc. /ID# 205836
Encinitas, California, 92024
Cedars Sinai Medical Group /ID# 170383
Encino, California, 91436-2731
Urology Associates of Colorado /ID# 170484
Englewood, Colorado, 80113-2700
Deaconess Clinic Downtown /ID# 167855
Evansville, Indiana, 47713-1227
Clinical Research Advantage, Inc. /ID# 170656
Evansville, Indiana, 47714-7513
MediSphere Medical Research Center /ID# 170317
Evansville, Indiana, 47714-8011
Dupage Medical Group /ID# 219039
Evergreen Park, Illinois, 60805-2735
Pharmakon Inc /ID# 206149
Evergreen Park, Illinois, 60805
NECCR PrimaCare Research, LLC /ID# 170326
Fall River, Massachusetts, 02721
Seven Corners Medical Center /ID# 170577
Falls Church, Virginia, 22044
Rapha Institute for Clinical Research /ID# 170362
Fayetteville, North Carolina, 28314-0260
Feasterville Family Health Care Center /ID# 168235
Feasterville, Pennsylvania, 19053
Med Research One /ID# 167923
Florissant, Missouri, 63031
G & L Research, LLC /ID# 170365
Foley, Alabama, 36535
S&W Clinical Research /ID# 170311
Fort Lauderdale, Florida, 33306
Invesclinic, U.S., LLC /ID# 202553
Fort Lauderdale, Florida, 33308
The Center for Diabetes and Endocrine Care /ID# 170373
Fort Lauderdale, Florida, 33312
Fountain Hills Family Practice P.C /ID# 170419
Fountain Hills, Arizona, 85268-3791
American Health Network of IN, LLC (Avon) /ID# 170483
Franklin, Indiana, 46131-9199
Village Health Partners - Legacy Medical Village /ID# 170659
Frisco, Texas, 75033-4135
St. Jude Hospital Yorba Linda /ID# 170437
Fullerton, California, 92835-3813
University of Florida - Hull Rd /ID# 170518
Gainesville, Florida, 32607
Malcom Randall VAMC /ID# 170645
Gainesville, Florida, 32608
AccuMed Research Associates /ID# 202200
Garden City, New York, 11530
San Gabriel Clinical Research /ID# 167929
Georgetown, Texas, 78626
Horizon Clinical Research Asoc /ID# 202937
Gilbert, Arizona, 85295
Lenzmeier Family Medicine /ID# 202945
Glendale, Arizona, 85308-5125
Arizona Internal Medicine Specialists, LLC- Glendale /ID# 203011
Glendale, California, 85306-4636
Allied Clinical Research /ID# 170519
Gold River, California, 95670
New West Physicians /ID# 203032
Golden, Colorado, 80401
Office of Bruce R. Gilbert, MD /ID# 202963
Great Neck, New York, 11021-5337
American Health Network of Indiana, LLC /ID# 202987
Greenfield, Wisconsin, 46140-2834
Bland Clinic, PA /ID# 204943
Greensboro, North Carolina, 27401-1033
Medication Management, LLC /ID# 205260
Greensboro, North Carolina, 27405-5634
Triad Clinical Trials /ID# 170376
Greensboro, North Carolina, 27410
Synexus Clinical Research US, Inc. /ID# 210237
Greer, South Carolina, 29651-1123
DeGarmo Institute of Medical Research /ID# 170528
Greer, South Carolina, 29651-1818
Fundamental Research /ID# 170504
Gulf Shores, Alabama, 36542
Clinical Investigation Specialists, Inc. /ID# 170631
Gurnee, Illinois, 60031
Alas Science Clinical Research /ID# 170352
Henderson, Nevada, 89014-0409
Synexus Clinical Research US, Inc. /ID# 210232
Henderson, Nevada, 89052-3992
Indago Research and Health Cen /ID# 170420
Hialeah, Florida, 33012-4170
OnSite Clinical Solutions, LLC - Hickory /ID# 202968
Hickory, North Carolina, 28601
Edward Hines Jr. VA Hospital /ID# 167944
Hines, Illinois, 60141-3030
Self Medical Group - Advanced /ID# 170336
Hodges, South Carolina, 29653
South Florida Research Solutions, LLC /ID# 167972
Hollywood, Florida, 33021-8284
Urology Centers of Alabama /ID# 206197
Homewood, Alabama, 35209
East-West Medical Research Institute /ID# 202959
Honolulu, Hawaii, 96814
East Texas Cardiology /ID# 170638
Houston, Texas, 77002
PrimeCare Medical Group /ID# 168146
Houston, Texas, 77024
Associates in Medicine, P.A. /ID# 170439
Houston, Texas, 77027-3103
Michael E. DeBakey VA Medical Center /ID# 167598
Houston, Texas, 77030-4211
Discovery MM Services, Inc - Katy /ID# 202958
Houston, Texas, 77036-7856
Centex Studies, Inc. - Houston /ID# 170537
Houston, Texas, 77058
Discovery MM Services, Inc - Houston - Broadway St /ID# 170558
Houston, Texas, 77061-1341
The Endocrine Center /ID# 170653
Houston, Texas, 77079
Texas Center for Drug Development, Inc. /ID# 170404
Houston, Texas, 77081
Village Medical-MCA /ID# 170443
Houston, Texas, 77084-5135
Methodist Urology Associates /ID# 170575
Houston, Texas, 77094
Endocrine and Psychiatry Cente /ID# 170520
Houston, Texas, 77095
Pioneer Research Solutions - Houston /ID# 170379
Houston, Texas, 77099-4307
Research Trials Worldwide /ID# 210694
Humble, Texas, 77338-3501
Marvel Clinical Research, LLC /ID# 170324
Huntington Beach, California, 92647
Longwood Research /ID# 201754
Huntsville, Alabama, 35801
Medical Affiliated Research Center, Inc. /ID# 170569
Huntsville, Alabama, 35801
Protenium Clinical Research /ID# 170397
Hurst, Texas, 76054
Institute of Arthritis Research /ID# 170495
Idaho Falls, Idaho, 83404-7883
Indiana-Armstrong Endocrinolgy /ID# 168249
Indiana, Pennsylvania, 15701
Richard L. Roudebush VA Medical Center /ID# 203020
Indianapolis, Indiana, 46202-2803
Urology of Indiana - Naab Road /ID# 203469
Indianapolis, Indiana, 46260
Irvine Center for Clinical Research /ID# 170368
Irvine, California, 92618
The University of Florida Heal /ID# 170450
Jacksonville, Florida, 32207-4966
Jacksonville Center for Clinical Research /ID# 170446
Jacksonville, Florida, 32216
Solutions Through Adv Rch /ID# 201590
Jacksonville, Florida, 32256
Care Partners Clinical Research /ID# 202520
Jacksonville, Florida, 32277
Synexus Clinical Research US, Inc. /ID# 210293
Jamaica, New York, 11432-1119
PMG Research of Knoxville /ID# 170393
Jefferson City, Tennessee, 37760
First Urology,PSC /ID# 167719
Jeffersonville, Indiana, 47130
Richard M Kastelic, MD and Ass /ID# 170382
Johnstown, Pennsylvania, 15905
Health Awareness, Inc - Port St Lucie /ID# 170507
Jupiter, Florida, 33458-2775
Holston Medical Group Clinical /ID# 168165
Kingsport, Tennessee, 37660
Texas Cardio Association of Ho /ID# 170494
Kingwood, Texas, 77339
New Phase Research & Development /ID# 170526
Knoxville, Tennessee, 37909
PMG Research of Knoxville /ID# 170451
Knoxville, Tennessee, 37912-4707
PMG Research of Knoxville /ID# 170514
Knoxville, Tennessee, 37938-4229
San Diego Clinical Trials /ID# 170468
La Mesa, California, 91942-3134
TriWest Research Associates- La Mesa /ID# 170498
La Mesa, California, 92108
Centex Studies, Inc /ID# 170416
Lake Charles, Louisiana, 70601
Meridien Research /ID# 167846
Lakeland, Florida, 33803-5918
Advanced Urology, PLLC dba Colorado Clinical Research /ID# 170406
Lakewood, Colorado, 80228-2271
FMC Science /ID# 170407
Lampasas, Texas, 76550
AB Clinical Trials /ID# 170612
Las Vegas, Nevada, 89119
Clinical Research of So Nevada /ID# 167594
Las Vegas, Nevada, 89122
Advanced Biomedical Research of America /ID# 202202
Las Vegas, Nevada, 89123
Palm Research Center, Inc. /ID# 168224
Las Vegas, Nevada, 89128-0463
Sheldon Freedman MD, ltd /ID# 170434
Las Vegas, Nevada, 89144
Physicians Research Associates, LLC /ID# 170313
Lawrenceville, Georgia, 30046
Tanner Clinic /ID# 168145
Layton, Utah, 84041
Wasatch Peak Family Practice / Synexus Clinical Research US, Inc. /ID# 210175
Layton, Utah, 84041
Northstate Clinical Research /ID# 170414
Lenoir, North Carolina, 28645
Family Medical Associates /ID# 170396
Levittown, Pennsylvania, 19056
WVVA Healthcare Alliance dba. /ID# 168246
Lewisburg, Ohio, 24901
Drs. Borders, Hood, and Assoc /ID# 170536
Lexington, Kentucky, 40503-2517
The Research Grp of Lexington /ID# 202900
Lexington, Kentucky, 40503-2969
Clinical Trials Research /ID# 210862
Lincoln, California, 95648
Ocean State Clin Rese Part,LLC /ID# 170547
Lincoln, Rhode Island, 02865
Main Street Physician's Care - Waterway /ID# 210441
Little River, South Carolina, 29566-8161
B.G. Clinical Research Center, LLC /ID# 170461
Little Rock, Arkansas, 72205
Preferred Research Partners /ID# 170539
Little Rock, Arkansas, 72211
Applied Research Center of Arkansas /ID# 170487
Little Rock, Arkansas, 72212-4187
Torrance Clinical Research Institute, Inc. /ID# 170307
Lomita, California, 90717
VA Long Beach Healthcare System /ID# 170374
Long Beach, California, 90822-5201
Tower Urology /ID# 170330
Los Angeles, California, 90048
University of Louisville /ID# 170607
Louisville, Kentucky, 40202
Manassas Clinical Research Center /ID# 201815
Manassas, Virginia, 20110-4421
South Florida Wellness & Clinic /ID# 170510
Margate, Florida, 33063
Awasty Research Network, LLC /ID# 210860
Marion, Ohio, 43302-6225
Tandem Clinical Research, LLC /ID# 206203
Marrero, Louisiana, 70072-3156
Advanced Medical Research /ID# 170488
Maumee, Ohio, 43537-9402
Centex Studies, Inc /ID# 203019
McAllen, Texas, 78504
Baptist Memorial Medical Group Endocrine Clinic /ID# 168061
Memphis, Tennessee, 38119
Clinical Neuroscience Solutions - Memphis /ID# 170559
Memphis, Tennessee, 38119
Methodist Medical Group /ID# 168148
Memphis, Tennessee, 38125
University of Tennessee Health /ID# 170321
Memphis, Tennessee, 38163
Solaris Clinical Research /ID# 202936
Meridian, Idaho, 83646
Synexus - Desert Clinical Research /ID# 170428
Mesa, Arizona, 85213
Panax Clinical Research /ID# 170525
Miami, Florida, 33014
Pharmax Research Clinic /ID# 170403
Miami, Florida, 33126
APF Research, LLC. /ID# 170412
Miami, Florida, 33134-2563
Well Pharma Medical Research /ID# 170337
Miami, Florida, 33143
Advanced Pharma CR, LLC /ID# 167840
Miami, Florida, 33147
Applemed Research Inc. /ID# 170364
Miami, Florida, 33155
New Horizon Research Center /ID# 170574
Miami, Florida, 33165-3372
Future Care Solution LLc /ID# 170361
Miami, Florida, 33165-3947
Care Research center Inc. /ID# 167924
Miami, Florida, 33175
Office of Francisco G Miranda, /ID# 203184
Miami, Florida, 33175
Floridian Research Institute LLC /ID# 167882
Miami, Florida, 33179
International Research Associates, LLC /ID# 170543
Miami, Florida, 33183
International Research Associates, LLC /ID# 170563
Miami, Florida, 33183
Quantum Clinical Trials /ID# 224233
Miami Beach, Florida, 33140
Meridian International Research, Inc. /ID# 202975
Miami Lakes, Florida, 33014-6435
LaPorte County Institute for Clinical Research, Inc. /ID# 170331
Michigan City, Indiana, 46360
Connecticut Clinical Research Center /ID# 207771
Middlebury (village), Vermont, 06762-1835
Virginia Research Center /ID# 170471
Midlothian, Virginia, 23114-3256
Facey Medical Foundation /ID# 203004
Mission Hills, California, 91345
Montana Medical Research /ID# 170579
Missoula, Montana, 59808
Discovery MM Services, Inc. /ID# 170562
Missouri City, Texas, 77459-4750
Mostellar Medical Center /ID# 170329
Mobile, Alabama, 36608-6705
Catalina Research Institute, LLC /ID# 170501
Montclair, California, 91763
PMG Research of Piedmont Healthcare /ID# 170341
Mooresville, North Carolina, 28117-5935
Carteret Medical Group LLC /ID# 170771
Morehead City, North Carolina, 28557
Diabetes & Endocrinology Consultants /ID# 201589
Morehead City, North Carolina, 28557
Koch Family Medicine SC /ID# 202205
Morton, Illinois, 61550-2495
PMG Research of Charleston /ID# 170572
Mt. Pleasant, South Carolina, 29464-1810
American Health Network of Indiana, LLC /ID# 170578
Muncie, Indiana, 47304
Synexus Clinical Research US, Inc. /ID# 168248
Murray, Utah, 84123-2967
Barnum Internal Medicine /ID# 170343
Natchitoches, Louisiana, 71457
Hill Country Medical Assoc /ID# 170444
New Braunfels, Texas, 78130
Tulane School of Medicine /ID# 170472
New Orleans, Louisiana, 70112
Mid Hudson Medical Research, PLLC /ID# 170511
New Windsor, New York, 12553-7754
Manhattan Medical Research /ID# 167956
New York, New York, 10016-6023
NewportNativeMD, Inc. /ID# 168110
Newport Beach, California, 92663-3600
Health Research of Hampton Roads, Inc. (HRHR) /ID# 204937
Newport News, Virginia, 23606
Clinical Research Associates of Tidewater /ID# 170609
Norfolk, Virginia, 23502-3932
Alliance for Multispecialty Research- Norman /ID# 170581
Norman, Oklahoma, 73071
Bravo Health Care Center /ID# 202201
North Bay Village, Florida, 33141-4188
Velocity Clinical Research, Inc. /ID# 168115
North Hollywood, California, 91606
DiGiovanna Institute for Medical Education & Research /ID# 170613
North Massapequa, New York, 11758
Harmony Clinical Research, Inc. /ID# 201816
North Miami Beach, Florida, 33162-1632
Valley Clinical Trials - Northridge Location /ID# 201587
Northridge, California, 91325-4108
Valley Renal Medical Group /ID# 170587
Northridge, California, 91325
Affinity Health /ID# 202552
Oak Brook, Illinois, 60523
Endocrine Associates of Florida, P.A. /ID# 167839
Ocoee, Florida, 34761-4547
Sensible Healthcare /ID# 170402
Ocoee, Florida, 34761
Advanced Research Institute - Ridgeline /ID# 170445
Ogden, Utah, 84405-6779
IPS Research Company /ID# 168117
Oklahoma City, Oklahoma, 73106
Lynn Health Science Institute East /ID# 170497
Oklahoma City, Oklahoma, 73111-3324
Lynn Health Science Institute (LHSI) /ID# 202973
Oklahoma City, Oklahoma, 73112
Olive Branch Family Med Ctr /ID# 170409
Olive Branch, Mississippi, 38654
VA Nebraska-Western Iowa Health Care System /ID# 167892
Omaha, Nebraska, 68105
Heartland Clinical Research /ID# 170541
Omaha, Nebraska, 68134
Meridian Clinical Research, LLC - Omaha /ID# 167836
Omaha, Nebraska, 68134
Clinical Research Advantage, Inc. /ID# 202966
Omaha, Nebraska, 68144
Synexus Clinical Research US Inc /ID# 170560
Omaha, Nebraska, 68144
Diabetes Associates Medical Group /ID# 170499
Orange, California, 92866-2862
Omega Research Group /ID# 170340
Orlando, Florida, 32808
Research Integrity, LLC /ID# 168264
Owensboro, Kentucky, 42303-1089
Desert Oasis Healthcare /ID# 170841
Palm Springs, California, 92262
IMIC Inc. Medical Research /ID# 167899
Palmetto Bay, Florida, 33157
Palmetto Institute of Clinical Research, Inc. /ID# 170395
Pelzer, South Carolina, 29669-1754
South Broward Research /ID# 170480
Pembroke Pines, Florida, 33027-1778
DBC Research USA /ID# 170332
Pembroke Pines, Florida, 33029
Phoenix Medical Group, PC /ID# 170516
Peoria, Arizona, 85381
DCT-AACT, LLC dba Discovery Clinical Trials /ID# 170394
Pflugerville, Texas, 78660
Founders Research Corp /ID# 170610
Philadelphia, Pennsylvania, 19114-1030
Phoenix VA Health Care System /ID# 167968
Phoenix, Arizona, 85012
Elite Clinical Studies, LLC /ID# 168058
Phoenix, Arizona, 85018
Family Practice Specialists /ID# 167859
Phoenix, Arizona, 85018
Central Phoenix Medical Clinic /ID# 170333
Phoenix, Arizona, 85020
Tatum Highlands Medical Assoc /ID# 208277
Phoenix, Arizona, 85050
Synexus Clinical Research US, Inc /ID# 209955
Pinellas Park, Florida, 33781
DMI Research, Inc. /ID# 170893
Pinellas Park, Florida, 33782
Allegheny Health Network /ID# 210544
Pittsburgh, Pennsylvania, 15212-4769
Pittsburgh VA Medical Center-University Drive /ID# 205837
Pittsburgh, Pennsylvania, 15219
ClinRx Research, LLC /ID# 203067
Plano, Texas, 75024-5280
DeLeon Research /ID# 210861
Plano, Texas, 75093-5279
Research Across America /ID# 168229
Plano, Texas, 75093
Clinical Research Center FL /ID# 202979
Pompano Beach, Florida, 33060
St. Johns Center /ID# 212654
Ponte Vedra, Florida, 32081
Charlotte Heart & Vascular Institute /ID# 202965
Port Charlotte, Florida, 33952
David M. Headley, MD, P.A. /ID# 205428
Port Gibson, Mississippi, 39150-2024
Saviers Medical Group /ID# 170327
Port Hueneme, California, 93041-2918
Puerto Rico5 sites
Emanuelli Research & Development Center LLC /ID# 206202
Arecibo, 00612
Research & Cardiovascular Corp /ID# 170353
Ponce, 00717
GCM Medical Group PSC /ID# 170466
San Juan, 00917-3104
Centro de Endocrinologia Alcantara-Gonzalez /ID# 207260
San Juan, 00956
Advanced Clinical Research /ID# 170553
Toa Baja, 00950
About this study
Official title: Testosterone Replacement Therapy for Assessment of Long-term Vascular Events and Efficacy ResponSE in Hypogonadal Men (TRAVERSE) Study
This is a double-blinded and placebo-controlled study of topical testosterone replacement therapy (TRT) in symptomatic hypogonadal men with pre-existing cardiovascular disease (CVD) or increased risk for CVD.
- Conditions
- Hypogonadism, Cardiovascular Diseases
- Being tested
- AndroGel®, Placebo
- Keywords
- hypogonadism, cardiovascular (CV) disease, AndroGel, testosterone replacement therapy (TRT)
- Medical subject headings
- Hypogonadism, Cardiovascular Diseases, Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
AndroGel®Drug
testosterone administered topically
PlaceboDrug
placebo administered topically
| Study group | Role | What they receive |
|---|---|---|
| AndroGel 1.62% | Active comparator | Participants receive topical testosterone starting with a 40.5 mg dose (2 pump actuations) of the study drug once daily (OD). Participants may receive a dose in the range of 20.25 mg (1 actuation) to 101.25 mg (5 actuations) in 20.25 mg increments during the course of the study if titrations are necessary. Receives: Drug: AndroGel® |
| Placebo | Placebo comparator | Participants receive matching placebo OD. Receives: Drug: Placebo |
What is being measured
The primary outcome is the main question the study is designed to answer.
Time From Randomization to the First Component Event of Major Adverse Cardiac Event (MACE): Number and Percentage of Participants With an Event
MACE is a composite endpoint including non-fatal myocardial infraction (MI), non-fatal stroke and cardiovascular (CV) death as adjudicated by Clinical Events Committee (CEC).
Measured: Randomization to event or last known date if no event (up to approximately 52 months)
Time From Randomization to the First Component Event of MACE
MACE is a composite endpoint including non-fatal MI, non-fatal stroke and CV death as adjudicated by CEC.
Measured: Randomization to event or last known date if no event (up to approximately 52 months)
Secondary outcomes (3)
Time From Randomization to the First Component Event of CV Safety Endpoint: Number and Percentage of Participants With an Event
The CV safety endpoint is a composite endpoint including non-fatal MI, non-fatal stroke, CV death, and coronary revascularization procedures/cardiac percutaneous coronary intervention (PCI), or coronary artery bypass graft (CABG) as adjudicated by CEC.
Measured: Randomization to event or last known date if no event (up to approximately 52 months).
Time From Randomization to the First Component Event of CV Safety Endpoint
The CV safety endpoint is a composite endpoint including non-fatal MI, non-fatal stroke, CV death, and coronary revascularization procedures/cardiac PCI, or CABG as adjudicated by CEC.
Measured: Randomization to event or last known date if no event (up to approximately 52 months).
Incidence of High-Grade Prostate Cancer
Presented as the number and percentage of participants with any high grade prostate cancer, defined as Gleason grade of 4 + 3 or higher, as adjudicated by Prostate Safety Events Committee (PAC). This grade is based on how abnormal prostate cells appear. Grade 1: cells look almost like normal prostate cells; Grade 5; cells look very different from normal prostate cells. Since most prostate cancers contain cells of different grades, the 2 most common grades are used. Gleason score is determined by adding the 2 most common grades. Higher numbers indicate a faster growing cancer that is more likely to spread. Currently the lowest score assigned to a tumor is grade 3. Grades below 3 show normal to near normal cells. Most cancers have a Gleason score (the sum of the 2 most common grades) of 6 (Gleason scores of 3+3) or 7 (Gleason scores of 3+4 or 4+3).
Measured: Randomization to event or last known date if no event (up to approximately 52 months).
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 May 2018
- Study start3 May 2018
- Primary completion19 Jan 2023
- Study completion19 Jan 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Publications (6)Papers the sponsor has linked to this study.
- Other trials for HypogonadismStudies of the same condition, open and under way.
- More trials run by AbbVieThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 5,246 participants (actual)
Sponsor and investigators
- Lead sponsor
- AbbVie
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Endo USA Inc., a Keenova Therapeutics Company, Acerus Pharmaceuticals Corporation, Allergan Sales, LLC, Upsher-Smith Laboratories
- Responsible party
- Sponsor
- Investigators
- ABBVIE INC., Study director, AbbVie
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03518034
- Sponsor's protocol ID
- M16-100
- Acronym
- TRAVERSE
- Status last verified
- Feb 2024
- First submitted
- 3 May 2018
- Last updated
- 13 Mar 2024
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- Yes
- FDA-regulated drug
- Yes
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Gagliano-Juca T, Pencina KM, Shang YV, Travison TG, Lincoff AM, Nissen SE, Artz AS, Li X, Chan A, Patel R, Miller MG, Bhasin S. Association of testosterone-induced increase in neutrophil and monocyte counts with thromboembolic events: The TRAVERSE trial. Am Heart J. 2025 Oct;288:77-88. doi: 10.1016/j.ahj.2025.04.004. Epub 2025 Apr 15.
PubMed 40246046Bhasin S, Lincoff AM, Nissen SE, Wannemuehler K, McDonnell ME, Peters AL, Khan N, Snabes MC, Li X, Li G, Buhr K, Pencina KM, Travison TG. Effect of Testosterone on Progression From Prediabetes to Diabetes in Men With Hypogonadism: A Substudy of the TRAVERSE Randomized Clinical Trial. JAMA Intern Med. 2024 Apr 1;184(4):353-362. doi: 10.1001/jamainternmed.2023.7862.
PubMed 38315466Snyder PJ, Bauer DC, Ellenberg SS, Cauley JA, Buhr KA, Bhasin S, Miller MG, Khan NS, Li X, Nissen SE. Testosterone Treatment and Fractures in Men with Hypogonadism. N Engl J Med. 2024 Jan 18;390(3):203-211. doi: 10.1056/NEJMoa2308836.
PubMed 38231621Bhasin S, Travison TG, Pencina KM, O'Leary M, Cunningham GR, Lincoff AM, Nissen SE, Lucia MS, Preston MA, Khera M, Khan N, Snabes MC, Li X, Tangen CM, Buhr KA, Thompson IM Jr. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Netw Open. 2023 Dec 1;6(12):e2348692. doi: 10.1001/jamanetworkopen.2023.48692.
PubMed 38150256Pencina KM, Travison TG, Artz AS, Lincoff AM, Nissen SE, Flevaris P, Chan A, Li X, Diegel SA, Wannemuehler K, Bhasin S. Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Netw Open. 2023 Oct 2;6(10):e2340030. doi: 10.1001/jamanetworkopen.2023.40030.
PubMed 37889486Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, Cunningham GR, Granger CB, Khera M, Thompson IM Jr, Wang Q, Wolski K, Davey D, Kalahasti V, Khan N, Miller MG, Snabes MC, Chan A, Dubcenco E, Li X, Yi T, Huang B, Pencina KM, Travison TG, Nissen SE; TRAVERSE Study Investigators. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023 Jul 13;389(2):107-117. doi: 10.1056/NEJMoa2215025. Epub 2023 Jun 16.
PubMed 37326322
Study at a glance
From the registry record, last updated by the sponsor on 13 Mar 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Testosterone Replacement Therapy for Assessment of Long-term Vascular Events and Efficacy ResponSE in Hypogonadal Men (TRAVERSE) Study
- ClinicalTrials.gov ID
- NCT03518034
- Acronym / sponsor ID
- TRAVERSE / M16-100
- Conditions
- Hypogonadism, Cardiovascular Diseases
- Keywords
- hypogonadism, cardiovascular (CV) disease, AndroGel, testosterone replacement therapy (TRT)
- Phase
- Phase 4
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 5,246 participants (actual)
- Lead sponsor
- AbbVieIndustry (pharma, biotech, devices)
- Collaborators
- Endo USA Inc., a Keenova Therapeutics Company, Acerus Pharmaceuticals Corporation, Allergan Sales, LLC, Upsher-Smith Laboratories
- Study start
- 3 May 2018 (actual)
- Primary completion
- 19 Jan 2023 (actual)
- Study completion
- 19 Jan 2023 (actual)
- First posted
- 8 May 2018 (actual)
- Results
- Posted 13 Mar 2024
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a double-blinded and placebo-controlled study of topical testosterone replacement therapy (TRT) in symptomatic hypogonadal men with pre-existing cardiovascular disease (CVD) or increased risk for CVD.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| AndroGel 1.62% | Active comparator | Drug: AndroGel®Participants receive topical testosterone starting with a 40.5 mg dose (2 pump actuations) of the study drug once daily (OD). Participants may receive a dose in the range of 20.25 mg (1 actuation) to 101.25 mg (5 actuations) in 20.25 mg increments during the course of the study if titrations are necessary. |
| Placebo | Placebo comparator | Drug: PlaceboParticipants receive matching placebo OD. |
Who may qualify
- Ages
- 45 to 80 years
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Men between 45 and 80 years age
- Participants with low serum testosterone concentrations (< 300 ng/dL) who exhibit at least one sign or symptom of hypogonadism and have evidence of cardiovascular (CV) disease or are at an increased risk for CV disease.
Key exclusion criteria (9 listed)
- Participants with congenital or acquired hypogonadism for whom long-term therapy with placebo would not be medically appropriate
- Participants with prostate specific antigen (PSA) > 3.0 ng/mL (or 1.5 if on 5-alpha reductase inhibitors)
- Participants who have been treated with testosterone in the past 6 months and for whom testosterone therapy is contraindicated
- Confirmed testosterone < 100 ng/dL
- Body Mass Index (BMI) > 50
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| AndroGel®testosterone administered topically | Drug | AndroGel 1.62% |
| Placeboplacebo administered topically | Drug | Placebo |
Primary outcome
Time From Randomization to the First Component Event of Major Adverse Cardiac Event (MACE): Number and Percentage of Participants With an Event
Time frame: Randomization to event or last known date if no event (up to approximately 52 months)
MACE is a composite endpoint including non-fatal myocardial infraction (MI), non-fatal stroke and cardiovascular (CV) death as adjudicated by Clinical Events Committee (CEC).
Time From Randomization to the First Component Event of MACE
Time frame: Randomization to event or last known date if no event (up to approximately 52 months)
MACE is a composite endpoint including non-fatal MI, non-fatal stroke and CV death as adjudicated by CEC.
3 secondary outcomes
Time From Randomization to the First Component Event of CV Safety Endpoint: Number and Percentage of Participants With an Event
Time frame: Randomization to event or last known date if no event (up to approximately 52 months).
Time From Randomization to the First Component Event of CV Safety Endpoint
Time frame: Randomization to event or last known date if no event (up to approximately 52 months).
Incidence of High-Grade Prostate Cancer
Time frame: Randomization to event or last known date if no event (up to approximately 52 months).
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Mar 2024.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Derived from this study: PubMed 40246046Gagliano-Juca T, Pencina KM, Shang YV, Travison TG, Lincoff AM, Nissen SE, Artz AS, Li X, Chan A, Patel R, Miller MG, Bhasin S. Association of testosterone-induced increase in neutrophil and monocyte counts with thromboembolic events: The TRAVERSE trial. Am Heart J. 2025 Oct;288:77-88. doi: 10.1016/j.ahj.2025.04.004. Epub 2025 Apr 15.
- Derived from this study: PubMed 38315466Bhasin S, Lincoff AM, Nissen SE, Wannemuehler K, McDonnell ME, Peters AL, Khan N, Snabes MC, Li X, Li G, Buhr K, Pencina KM, Travison TG. Effect of Testosterone on Progression From Prediabetes to Diabetes in Men With Hypogonadism: A Substudy of the TRAVERSE Randomized Clinical Trial. JAMA Intern Med. 2024 Apr 1;184(4):353-362. doi: 10.1001/jamainternmed.2023.7862.
- Derived from this study: PubMed 38231621Snyder PJ, Bauer DC, Ellenberg SS, Cauley JA, Buhr KA, Bhasin S, Miller MG, Khan NS, Li X, Nissen SE. Testosterone Treatment and Fractures in Men with Hypogonadism. N Engl J Med. 2024 Jan 18;390(3):203-211. doi: 10.1056/NEJMoa2308836.
- Derived from this study: PubMed 38150256Bhasin S, Travison TG, Pencina KM, O'Leary M, Cunningham GR, Lincoff AM, Nissen SE, Lucia MS, Preston MA, Khera M, Khan N, Snabes MC, Li X, Tangen CM, Buhr KA, Thompson IM Jr. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Netw Open. 2023 Dec 1;6(12):e2348692. doi: 10.1001/jamanetworkopen.2023.48692.
- Derived from this study: PubMed 37889486Pencina KM, Travison TG, Artz AS, Lincoff AM, Nissen SE, Flevaris P, Chan A, Li X, Diegel SA, Wannemuehler K, Bhasin S. Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Netw Open. 2023 Oct 2;6(10):e2340030. doi: 10.1001/jamanetworkopen.2023.40030.
- Derived from this study: PubMed 37326322Lincoff AM, Bhasin S, Flevaris P, Mitchell LM, Basaria S, Boden WE, Cunningham GR, Granger CB, Khera M, Thompson IM Jr, Wang Q, Wolski K, Davey D, Kalahasti V, Khan N, Miller MG, Snabes MC, Chan A, Dubcenco E, Li X, Yi T, Huang B, Pencina KM, Travison TG, Nissen SE; TRAVERSE Study Investigators. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023 Jul 13;389(2):107-117. doi: 10.1056/NEJMoa2215025. Epub 2023 Jun 16.
- Related InfoLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Hypogonadism
RecruitingObservational study
Inherited Reproductive Disorders
Genetic Disorder, Infertility
RecruitingPhase 2
Clinical Trial to Observe the Effects of Tamoxifen on Testosterone Recovery in Medically Castrated Prostate Cancer Patients
Hypogonadism, Prostate Cancer
Not yet recruitingPhase 2
HRT-PC Trial: Hormone Recovery After Treatment for Prostate Cancer Trial. An Open-label Phase II Study of Clomiphene Citrate in Patients With Persistent Hypogonadism After ADT for Treatment of Localized Prostate Cancer
Prostate Cancer
Active, not recruitingPhase 2
Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity
Hypothalamic Obesity, Hypothalamic Tumor
Active, not recruitingPhase 1/2
A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
Hypothalamic Obesity, Prader-Willi Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
ABBVIE INC. study director
AbbVie
384 sites in 2 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 4 study testing AndroGel® in people with Hypogonadism and Cardiovascular Diseases, run by AbbVie at 384 sites in 2 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 13 Mar 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 384 sites in United States, Puerto Rico. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
Yes. Results are posted in the registry (first posted 13 Mar 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Time From Randomization to the First Component Event of Major Adverse Cardiac Event (MACE): Number and Percentage of Participants With an Event (time frame: Randomization to event or last known date if no event (up to approximately 52 months)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03518034, which also lists 6 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2024.